Additionally, after treating with cisplatin, mice with sh-NEAT1 injection displayed a smaller tumor volume and weight, which suggested that inhibition of NEAT1 repressed tumor cell resistance to cisplatin in vivo (Figures 3B,C). Here, NEAT1 is linked to neoplasm.